More importantly, contrary to the general belief that CAFs invariably promote tumor progression, targeting CAFs has been shown to exacerbate the disease in PAAD and mouse models [15, 16], implying that different CAFs subsets may perform opposing roles in disease progression. This evidence concerns the gene TBX1 and pancreatic adenocarcinoma.